Differences in risk behaviour at baseline or during the study , or annualised dropout rate ( 77 % [ 95 % CI 62-95 ] for vaccine recipients vs 88 % [ 71-107 ] for placebo recipients ; p = 040 ) are unlikely explanations for the increased rate of HIV-1 infections seen in vaccine recipients .